LoginSignup
Spero logo

Spero

Stock
Stock
ISIN: US84833T1034
Ticker: SPRO
US84833T1034
SPRO

Price

Price

Historical dividends and forecast

All dividend data

 

$0.0508

CHART BY

Frequently asked questions

What is Spero's market capitalization?

The market capitalization of Spero is $64.88M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Spero's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Spero is 19.54. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Spero?

Spero's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.0609. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Spero's stock?

Currently, 4 analysts cover Spero's stock, with a consensus target price of $7.50. Analyst ratings provide insights into the stock's expected performance.

What is Spero's revenue over the trailing twelve months?

Over the trailing twelve months, Spero reported a revenue of $106.46M.

What is the EBITDA for Spero?

Spero's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$1.03M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Spero?

Spero has a free cash flow of -$17.54M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Spero's stock?

The 5-year beta for Spero is 0.61. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Spero have, and what sector and industry does it belong to?

Spero employs approximately 46 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Spero's shares?

The free float of Spero is 43.54M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $64.88M

5Y beta

 0.61

EPS (TTM)

 $0.0609

Free Float

 43.54M

P/E ratio (TTM)

 19.54

Revenue (TTM)

 $106.46M

EBITDA (TTM)

 -$1.03M

Free Cashflow (TTM)

 -$17.54M

Pricing

1D span
$1.094$1.192
52W span
$1.01$1.89

Analyst Ratings

The price target is $7.50 and the stock is covered by 4 analysts.

Buy

3

Hold

1

Sell

0

Information

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections with unmet need. Its lead product candidate, SPR720, is an oral antimicrobial agent in development for the treatment of nontuberculous mycobacterial (NTM) pulmonary disease, a rare orphan disease. Its partnership-directed programs consist of tebipenem HBr and SPR206. The tebipenem HBr is designed to be the oral carbapenem-class antibiotic for use to treat certain bacterial infections that cause complicated urinary tract infections (cUTIs), including pyelonephritis, caused by certain microorganisms, in adult patients who have limited oral treatment options. SPR206 is a direct acting intravenous (IV)-administered product candidate being developed as an option to treat MDR Gram-negative bacterial infections in the hospital setting.

46

Biotechnology & Drugs

Health Care

Identifier

ISIN

US84833T1034

Primary Ticker

SPRO

Knockouts

Join the conversation
Sign upLogin